Table III.
Association between the expression of sPLA2-II and clinicopathological variables.
| sPLA2-II expression | ||||
|---|---|---|---|---|
| Clinicopathological feature | n | Low, n (%) | High, n (%) | P-value |
| Gender | 0.229 | |||
| Male | 44 | 13 (29.5) | 31 (70.5) | |
| Female | 21 | 3 (14.3) | 18 (85.7) | |
| Age, years | 0.076 | |||
| ≤65 | 41 | 13 (31.7) | 26 (63.4) | |
| >65 | 24 | 3 (12.5) | 23 (87.5) | |
| Tumor diameter, cm | 0.243 | |||
| ≤3 | 27 | 9 (33.3) | 18 (66.7) | |
| >3 | 41 | 7 (18.4) | 9 (81.6) | |
| Helicobacter pylori infection | 0.332 | |||
| Negative | 25 | 20 (80.0) | 5 (20.0) | |
| Positive | 40 | 30 (75.0) | 10 (25.0) | |
| Tumor stage | 0.021 | |||
| I | 48 | 8 (16.7) | 40 (83.3) | |
| II | 17 | 8 (47.1) | 9 (52.9) | |
| Histological gradea | <0.001 | |||
| 3 | 34 | 2 (5.9) | 32 (94.1) | |
| 1 and 2 | 31 | 14 (45.2) | 17 (54.8) | |
sPLA2-II, secretory phospholipase A-Group IIA.
a
1, well differentiated; 2, moderately differentiated; 3, poorly differentiated.